Crossref
Diagnostic Value of PSA Screening Combined with Multiparametric MRI in Differentiating Prostate Cancer in the PSA Gray Zone (4.0–10.0 ng/mL)
Research journal · 2025 · 1 (1)
DOI: 10.65281/736336 ↗Kurz gefasst
Fachartikel in der Zeitschrift Research journal, 2025. Verfasst von Senlin Hou und 8 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Hou, S., Xiong, M., Xu, B., Zhao, D., Du, Z., Fu, D., Lu, W., Hou, J., & Chen, W. (2025). Diagnostic Value of PSA Screening Combined with Multiparametric MRI in Differentiating Prostate Cancer in the PSA Gray Zone (4.0–10.0 ng/mL). Research journal, 1(1). https://doi.org/10.65281/736336
Vancouver
Hou S, Xiong M, Xu B, Zhao D, Du Z, Fu D, et al. Diagnostic Value of PSA Screening Combined with Multiparametric MRI in Differentiating Prostate Cancer in the PSA Gray Zone (4.0–10.0 ng/mL). Research journal. 2025;1(1). doi:10.65281/736336
BibTeX
@article{Hou2025,
author = {Hou, Senlin and Xiong, Ming and Xu, Binxian and Zhao, Duze and Du, Zhinan and Fu, Dongjun and Lu, Wei and Hou, Junqing and Chen, Weiguo},
title = {Diagnostic Value of PSA Screening Combined with Multiparametric MRI in Differentiating Prostate Cancer in the PSA Gray Zone (4.0–10.0 ng/mL)},
journal = {Research journal},
year = {2025},
volume = {1},
number = {1},
doi = {10.65281/736336}
}
EUVIMED